Abstract
In recent years, our understanding of the genetic basis of cancer has been greatly enhanced by the discovery of molecular elements involved in cell transformation such as the oncogenes, capable of neoplastically transforming certain rodent cells via DNA transfection (Land et al. 1983), and tumor suppressor genes. The latter were originally discovered by somatic cell-hybridization experiments via whole cell fusion revealing that the cancerous phenotype could be suppressed by the introduction of normal genetic information (Harris et al. 1969; Stanbridge 1976). Meanwhile, more than 50 types of oncogenes are known and an increasing number of “tumor suppressor genes” are being detected and cloned (for reviews see Stanbridge 1990; Bishop 1991).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baden HP, Kubilius J, Kredar JC, Steinberg ML, Wolman SR (1987) Isolation and characterization of a spontaneously arising long-lived line of human keratinocytes (NM1). In Vitro Cell Dev Biol 23: 205–213
Banks L, Matlashewski G, Crawford L (1986) Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 159: 529–534
Barrett JC (1991) Comparison of human versus rodent cell transformation: importance of cell aging. In: Rhim J, Dritschilo A (eds) Neoplastic transformation in human cell systems in vitro. Humana, Totowa
Bishop M (1991) Molecular themes in oncogenesis. Cell 64: 235–248
Boukamp P, Fusenig NE (1992) Trans-differentiation from epidermal to mesenchymal/ myogenic phenotype is associated with a drastic change in cell-cell and cell-matrix adhesion molecules. J Cell Biol
Boukamp P, Tilgen W, Dzarliewa RT, Breitkreutz D, Haag D, Riehl RK, Bohnert A, Fusenig NE (1982) Phenotypic and genotypic characteristics of a cell line from a squamous cell carcinoma of human skin. J Natl Cancer Inst 68: 415–427
Boukamp P, Rupniak THR, Fusenig NE (1985) Environmental modulation of the expression of differentiation and malignancy in six human squamous cell carcinoma cell lines. Cancer Res 45: 5582–5592
Boukamp P, Dzarliewa-Petrusevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761–771
Boukamp P, Breitkreutz D, Stark H-J, Fusenig NE (1990a) Mesenchyme-mediated and endogenous regulation of growth and differentiation of human skin keratinocytes derived from different body sites. Differentiation 44: 150–161
Boukamp P, Stanbridge EJ, Foo DY, Cerutti PA, Fusenig NE (1990b) C-Ha-ras oncogene expression in immortalized human keratinocytes ( HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res 50: 2840–2847
Boukamp P, Chen J, Gonzales F, Jones PA, Fusenig NE (1992) Progressive stage of “trans-differentiation” from epidermal to mesenchymal phenotype induced by MyoD1 transfection, 5-aza-2’ deoxyctidine treatment, and selection for reduced cell attachment in the human keratinocyte line HaCaT. J Cell Biol 116: 1257–1271
Boyd JA, Barrett JC (1990) Genetic and cellular basis of multistep carcinogenesis. Pharmacol Ther 46: 469–486
Breitkreutz D, Hornung J, Pöhlmann J, Brown-Biermann L, Bohnert A, Bowden PE, Fusenig NE (1986) Environmental induction of differentiation-specific keratins in malignant mouse keratinocyte lines. Europ J Cell Biol 42: 255–267
Breitkreutz D, Boukamp P, Stark H-J, Ryle C, Fusenig NE (1989) Response of established keratinocyte lines to modulators of epidermal differentiation. In: Pharmacology and the Skin, vol 3. Karger, Basel, pp 8–14
Breitkreutz D, Boukamp P, Ryle CM, Stark H-J, Roop DR, Fusenig NE (1991) Epidermal morphogenesis and keratin expression in c-Ha-ras-transfected tumorigenic clones of the human HaCaT cell line. Cancer Res 51: 4402–44409
Bremner R, Balmain A (1990) Genetic changes in skin tumor progression: correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell 61: 407–417
Edelman GM (1986) Cell adhesion molecules in the regulation of animal form and tissue pattern. Annu Rev Cell Biol 2: 81–116
Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759–767
Fournier REK, Ruddle FH (1977) Microcell-mediated transfer of murine chromosomes into mouse, chinese hamster, and human somatic cells. Proc Natl Sci USA 74: 319–323
Fusenig NE, Breitkreutz D, Dzarliewa RT, Boukamp P, Bohnert A, Tilgen W (1983) Growth and differentiation characteristics of transformed keratinocytes from mouse and human skin in vitro and in vivo. J Invest Dermatol 81: 168s - 175s
Fusenig NE, Dzarliewa-Petrusevska RT, Breitkreutz D (1985) Phenotypic and cytogenetic characteristics of different stages during spontaneous transformation of mouse keratinocytes in vitro. In: Barrett JC, Tennant RW (eds) Carcinogenesis, vol 9. Raven, New York, pp 293–326
Fusenig NE, Boukamp P, Breitkreutz D, Hülsen A, Karjetta S, Stanbridge E (1989) Transformation of human skin epithelial cells in vitro: concepts and stages of transformation. In: Chadwick KH, Seymour C, Barnhard B (eds) Cell transformation and radiation-induced cancer. Hilger, Bristol, pp 45–56
Fusenig NE, Boukamp P, Breitkreutz D, Hülsen A, Petrusevska RT, Cerutti P, Stanbridge E (1990) In vitro transformation of human skin epithelial cells: role of ras oncogene in malignant progression. Toxicol In Vitro 4: 627–634
Fusenig NE, Breitkeutz D, Boukamp P (1991a) Differentiation potential of cancer cells. In: Masters J (ed) Human cancer in primary culture. A handbook. Kluwer Dordrecht, pp 55–80
Fusenig NE, Boukamp P, Breitkreutz D, Hülsen A (1991b) Altered regulation of growth and differentiation at different stages of transformation of human skin keratinocytes. In: Rhim J, Dritschilo A (eds) Neoplastic transformation in human cell systems in vitro. Humana, New Jersey
Gannon JV, Greaves R, Iggo R, Lane DP (1990) Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 9: 1595–1602
Good DJ, Polverini PJ, Rastinead F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP (1990) A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 87: 6624–6628
Harris H, Miller UJ, Klein G, Worst P, Tachibana T (1969) Suppression of malignancy by cell fusion. Nature 223: 363–368
Henrad DR, Thornley AT, Brown LM, Rheinwald JG (1990) Specific effects of ras oncogene expression on the growth and histogenesis of human epidermal keratinocytes. Oncogene 5: 475–481
Jenkins JR, Rudge K, Currie GA (1984) Cellular immortalization by a cDNA clone encoding the transformation-associated phospho-protein p53. Nature 312: 651–654
Kerbel RS (1990) Growth dominance of the metastatic cancer cell: cellular and molecular aspects. Adv Cancer Res 55: 87–132
Land H, Parada LF, Weinberg K (1983) Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304: 596–602
Lane DP, Benchimol S (1990) p53: oncogene or anti-oncogene? Genes Dev 4:1–8
Lehmann TA, Modah R, Stanek J, Welsh J, Bennett WP, Stampfer M, Boukamp P, Fusenig NE, Harris CC (1993) P53 mutations in human immortalized epithelial cell lines. Carcinogenesis (in press)
McKenna WG, Nkahara K, Muschel RJ (1988) Site specific integration of Ha-ras in transformed rat embryo cells. Science 241: 1325–1327
Pierceall WE, Goldberg LH, Tainsky MA, Mukhopadhyay T, Ananthaswamy HN (1991) Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol Carcinog 4: 196–202
Rhim JS (1989) Neoplastic transformation of human epithelial cells in vitro. Anticancer Res 9: 1345–1366
Rhim JS, Dritschilo A (eds) (1991) Neoplastic transformation in human cell systems in vitro. Humana, Totowa
Roop DR, Lowy DR, Tambourin PE, Strickland J, Harper JR, Balaschak M, Spangler EF, Yuspa SH (1986) An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue. Nature 323: 822–824
Ryle CM, Breitkreutz D, Stark H-J, Leigh IM, Steinert PM, Roop D, Fusenig NE (1989) Density-dependent modulation of synthesis of keratins 1 and 10 in the human keratinocyte line HaCaT and in ras-transfected tumorigenic clones. Differentiation 40: 42–54
Sager R (1984) Resistance of human cells to oncogenic transformation. Cancer Cells 2: 487–493
Saxon PJ, Srivatsan ES, Leipzig GV, Sameshima JH, Stanbridge EJ (1985) Selective transfer of individual human chromosomes to recipient cells. Mol Cell Biol 5: 140–146
Stanbridge EJ (1976) Suppression of malignancy in human cells. Nature 260: 17–20
Stanbridge EJ (1990) Human tumor suppressor genes. Annu Rev Genet 24: 615–657
Sugawara S, Oshimura M, Koi M, Annab LA, Barrett JC (1990) Induction of cellular senescence in immortalized cells by human chromosome 1. Science 247: 707–710
Tilgen W, Boukamp P, Breitkreutz D, Dzarliewa RT, Engstner M, Haag D, Fusenig NE (1983) Preservation of morphological, functional and karyotypic traits during long-term culture and in vivo passage of two human skin squamous cell carcinomas. Cancer Res 43: 5995–6011
Vlemincks K, Vakaet Jr L, Mareel M, Fiers W, Van Roy F (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66: 107–119
Watt F, Boukamp P, Hornung J, Fusenig NE (1987) Effect of growth environment on spatial expression of involucrin by human epidermal keratinocytes. Arch Dermatol Res 279: 335–340
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Boukamp, P., Breitkreutz, D., Hülsen, A., Altmeyer, S., Tomakidi, P., Fusenig, N.E. (1993). In Vitro Transformation and Tumor Progression. In: Hecker, E., Jung, E.G., Marks, F., Tilgen, W. (eds) Skin Carcinogenesis in Man and in Experimental Models. Recent Results in Cancer Research, vol 128. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84881-0_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-84881-0_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84883-4
Online ISBN: 978-3-642-84881-0
eBook Packages: Springer Book Archive